Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Steris

Close the acquisition of Cantel Medical Corp. by end of first quarter fiscal 2022

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
12 Jan 2021
Due
30 Jun 2021
Delivered
2 Jun 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is anticipated to close by the end of STERIS's first quarter of fiscal 2022 (ending June 30, 2021), pending customary closing conditions including receipt of regulatory approvals and approval by Cantel stockholders.”
  • SourceSteris Form 8-K press release, 2021-01-12
  • FilingSEC filing index
  • Deadline as statedby the end of STERIS's first quarter of fiscal 2022 (ending June 30, 2021)
  • Deadline used30 Jun 2021, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2021-STE-006370
    Cite as https://keptindex.org/c/KI-C-2021-STE-006370/ — this address never changes.

What we found

Evidence strength A What the grades mean

The 10-K filed 2022-05-31 states STERIS acquired all outstanding equity of Cantel Medical LLC on June 2, 2021, before the June 30, 2021 deadline.

  • A
    Steris 10-K filed 2022-05-31 Regulatory filing · published 31 May 2022 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint d40089e58391
    “On June 2, 2021, we acquired all outstanding equity interests in Cantel Medical LLC ("Cantel") through a U.S. subsidiary.” ✓ confirmed on the page

Market reaction: the shares moved -3.8% against the S&P 500 over the three sessions around the disclosure (27 May 2022 to 2 Jun 2022). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
Acquisition of Cantel Medical Corp.
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: pending customary closing conditions; receipt of regulatory approvals; approval by Cantel stockholders
Depends on
Regulatory, Shareholder, Government

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Steris? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-STE-006370 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.